NFKB1 and hepatocellular carcinoma: Further investigations revealed that IF1 promotes EMT and angiogenesis via the NF-κB signaling pathway, while also diminishing the sensitivity of HCC cells to sorafenib following IRFA (Kong et al., 2020).